FGFR3 and achondroplasia: We have recently successfully developed a recombinant protein treatment, using a decoy soluble FGFR3 (sFGFR3), restoring full bone growth in mice carrying the achondroplasia mutation (Fgfr3ach/+) [6] opening the way of potential treatment in humans.